Skip to main content

Advertisement

Figure 3 | BMC Cancer

Figure 3

From: Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study

Figure 3

Survival curves in patients with early HCC. The difference in survival among groups according to treatment modality is highly statistically significant (p = 0.0001) [OLTx mean survival 106 months (CI 89–124); Surgical resection median survival 52 months (CI 45–58), RFTA 62 months, PEI 44 months (CI 37–50), TACE alone 34 months (CI 29–39), TACE+PEI 41 months (CI 27–54), BSC 28 months (CI 17–39)]. (OLTx: orthotopic liver transplantation; RFTA: radiofrequency-mediated thermal ablation; PEI: percutaneous ethanol injection; TACE: transcatheter arterial chemoembolization; BSC: best supportive care).

Back to article page